Stem cell technology is emerging as one of the Mucopolysaccharidosis (MPS) treatment
Mucopolysaccharides are more popularly known are long linear, non-repetitious polysaccharide units containing at least one non-lactose sugar with an attached galactose sugar. The repeating two-dimensional sugar unit is composed of amino acid and uric acid, excluding mucopolysaccharides, where in place of the amino acid it contains galactose; the non-galactose sugar, on the other hand, is either glucose or galactose. Mucopolysaccharides are produced in the intestines through a series of events. First, the ingested food supplies the enzymes required for glycolysis, the process that produces energy from glucose. Glucose is transported to the liver for conversion into glycogen, a material that stores fat and prevents glycolysis from being inhibited. The liver then transports the glycogen back to the small intestine where it is incorporated into long chains of glucose-free glucose and transported back into the bloodstream. These long chains eventually exit the body in the urine. Mucop